-
Allen M I, Deslauriers M, Andrews C W. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group[J]. Hepatology, 1998, 27(): 1670-1677. doi: 10.1002/(ISSN)1527-3350
-
Bartholomeusz A, Locarnini S. Hepatitis B virus mutations associated with antiviral therapy[J]. J Med Virol, 2006, 78(Suppl 1): S52-S55.
-
Baumert T F, Rogers S A, Hasegawa K. Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication[J]. J Clin Invest, 1996, 98(): 2268-2276. doi: 10.1172/JCI119037
-
Baumert T F, Yang C, Schurmann P. Hepatitis B virus mutations associated with fulminant hepatitis induce apoptosis in primary Tupaia hepatocytes[J]. Hepatology, 2005, 41(): 247-256. doi: 10.1002/hep.v41:2
-
Blackberg J, Kidd-Ljunggren K. Mutations within the hepatitis B virus genome among chronic hepatitis B patients with hepatocellular carcinoma[J]. J Med Virol, 2003, 71(): 18-23. doi: 10.1002/jmv.v71:1
-
Blum H E. Hepatitis B virus: significance of naturally occurring mutants[J]. Intervirology, 1993, 35(): 40-50. doi: 10.1159/000150294
-
Domingo E, Gonzalez-Lopez C, Pariente N. Population dynamics of RNA viruses: the essential contribution of mutant spectra[J]. Arch Virol, 2005, (Suppl): 59-71.
-
Farci P, Quinti I, Farci S. Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively[J]. Proc Natl Acad Sci USA, 2006, 103(): 8475-8480. doi: 10.1073/pnas.0602546103
-
Lok A S, McMahon B J. Chronic hepatitis B: update of recommendations[J]. Hepatology, 2004, 39(): 857-861. doi: 10.1002/hep.v39:3
-
Lok A S, McMahon B J. Chronic hepatitis B[J]. Hepatology, 2007, 45(): 507-539. doi: 10.1002/hep.v45:2
-
Martin V, Perales C, Davila M. Viral fitness can influence the repertoire of virus variants selected by antibodies[J]. J Mol Biol, 2006, 362(): 44-54. doi: 10.1016/j.jmb.2006.06.077
-
Milich D R, Jones J E, Hughes J L. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?[J]. Proc Natl Acad Sci USA, 1990, 87(): 6599-6603. doi: 10.1073/pnas.87.17.6599
-
Ogata N, Miller R H, Ishak K G. The complete nucleotide sequence of a pre-core mutant of hepatitis B virus implicated in fulminant hepatitis and its biological characterization in chimpanzees[J]. Virology, 1993, 194(): 263-276. doi: 10.1006/viro.1993.1257
-
Pallier C, Castera L, Soulier A. Dynamics of hepatitis B virus resistance to lamivudine[J]. J Virol, 2006, 80(): 643-653. doi: 10.1128/JVI.80.2.643-653.2006
-
Ray S C, Mao Q, Lanford R E. Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees[J]. J Virol, 2000, 74(): 3058-3066. doi: 10.1128/JVI.74.7.3058-3066.2000
-
Ray S C, Wang Y M, Laeyendecker O. Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy[J]. J Virol, 1999, 73(): 2938-2946.
-
Wang Y M, Ray S C, Laeyendecker O. Assessment of hepatitis C virus sequence complexity by electrophoretic mobilities of both single-and double-stranded DNAs[J]. J Clin Microbiol, 1998, 36(): 2982-2989.
-
Yamada G, Takaguchi K, Matsueda K. Immunoelectron microscopic observation of intrahepatic HBeAg in patients with chronic hepatitis B[J]. Hepatology, 1990, 2(): 133-140.
-
Yim H J, Hussain M, Liu Y. Evolution of multi-drug resistant hepatitis B virus during sequential therapy[J]. Hepatology, 2006, 44(): 703-712. doi: 10.1002/(ISSN)1527-3350